Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Naloxone 0,4 Mg/ml Ampoule
Orpha Swiss GmbH Switzerland flag Switzerland
Abstract ID:
Opioid receptor antagonist reducing opioid induced respiratory depression...
Contact
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Competitive antagonist on opioid reptors. Inhibits opioid induced respiratory depression.

Strong Opioid-antagonist for postoperative use and in emergency after overdose of e.g. Heroine. Target groups are anaesthetists and hospitals (accident and emergency units). The product is a generic and supplied in packs of 10 ampoules.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Country specific or regional distribution contract.

FEATURED
Last Updated Oct 2014
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FDA APPROVED / FINISHED PRODUCT
CORPORATION
Company Logo